| 258 | 0 | 34 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨侵袭性肺曲霉病的早期诊断与治疗。方法 对1例侵袭性肺曲霉病的临床资料进行回顾性研究，并复习文献。结果 本例患者经过严格的抗真菌治疗之后，病情有所好转，无其他并发症及死亡发生。结论 在临床上，要详细询问病史，通过影像学检查，尽快完善血清、肺泡灌洗液GM试验和血清G试验等，做到早诊断、早治疗，改善IPA患者的预后，降低病死率。
Abstract：Objective To explore the early diagnosis and treatment of invasive pulmonary aspergillosis. Methods The clinical data of 1 case with invasive pulmonary aspergillosis were retrospectively studied and the literature was reviewed. Results After strict antifungal therapy,the patient′s condition improved and no other complications or death occurred.Conclusion In clinical practice,it is necessary to inquire about the medical history in detail and improve the serum,alveolar lavage fluid GM test,and serum G test as soon as possible through imaging examination, to achieve early diagnosis and treatment, improve the prognosis of IPA patients,and reduce the mortality.
[1] LOCKHART S R,FRADE J P,ETIENNE K A,et al. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene[J]. Antimicrobial Agents and Chemotherapy,2011,55(9):4465-4468.
[2] DONNELLY J P,CHEN S C,KAUFFMAN C A,et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium[J]. Clinical Infectious Diseases,2020,71(6):1367-1376.
[3] MAHMOUD M I,ELFAKI A,ALHAJ Z A,et al. Allergic bronchopulmonary aspergillosis with an atypical mass-like presentation[J]. Case Rep Pulmonol,2022,2022:3627202. DOI:10.1155/2022/3627202.
[4]王世雄，张昊川，李由，等.支气管扩张症患者中肺曲霉病的研究进展[J].新医学，2022,53(10):718-722.
[5] LEDOUX M P,GUFFROY B,NIVOIX Y,et al. Invasive pulmonary aspergillosis[J]. Semin Respir Crit Care Med,2020,41(1):80-98.
[6]周建林，曹颖平，张晓琍，等.非粒细胞缺乏患者侵袭性肺曲霉菌感染的早期诊断价值[J].中华检验医学杂志，2018,41(11):837-840.
[7] TACCONE F S,VAN DEN ABEELE A M,BULPA P,et al. Epidemiology of invasive aspergillosis in critically ill patients:clinical presentation,underlying conditions,and outcomes[J]. Critical Care,2015,19(1):7.
[8] DAI Z,ZHAO H,CAI S,et al. Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease:a single-centre retrospective analysis of 52 subjects[J]. Respirology,2013,18(2):323-331.
[9]王丽君.非粒细胞缺乏患者侵袭性肺曲霉菌感染的早期诊断价值[J].家庭医药，2020(1):239.
[10] ZHANG R,WANG S,LU H,et al. Misdiagnosis of invasive pulmonary aspergillosis:a clinical analysis of26 immunocompetent patients[J]. Int J Clin Exp Med,2014,7(12):5075-5082.
[11]中国医师协会血液科医师分会，中国侵袭性真菌感染工作组.血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则（第六次修订版）[J].中华内科杂志，2020,59(10):754-763.
[12]高东田，刘利华，申爱华，等.侵袭性肺曲霉菌感染实验诊断新进展[J].检验医学，2021,36(4):453-461.
[13]王东江，郭建.侵袭性真菌感染实验室诊断研究进展[J].检验医学，2023,38(2):179-185.
[14]刘利华，李建美，董海新，等.支气管肺泡灌洗液GM试验联合血清GM试验对侵袭性肺曲霉病的诊断价值[J].中华危重病急救医学，2019(3):331-335.
[15] HELDT S,HOENIGL M. Lateral flow assays for the diagnosis of invasive aspergillosis:Current status[J].Curr Fungal Infect Rep,2017,11(2):45-51.
[16]施毅.非粒缺患者侵袭性肺真菌病诊疗思路[J].中国临床研究，2023,36(4):481-486.
[17] DICHTL K,FORSTER J,ORMANNS S,et al. Comparison of β-D-Glucan and galactomannan in serum for detection of invasive aspergillosis:Retrospective analysis with focus on early diagnosis[J]. J Fungi(Basel),2020,6(4):253.
[18]马艳良.肺部曲霉菌感染的诊断与治疗[J].临床内科杂志，2020,37(10):689-692.
[19]井然，郭大文，王俊瑞，等.艾沙康唑、伏立康唑、两性霉素B对我国多中心临床分离丝状真菌的体外药物敏感性评估[J].中国合理用药探索，2022,19(12):78-84.
[20] TISSOT F,AGRAWAL S,PAGANO L,et al. ECIL-6 guidelines for the treatment of invasive candidiasis,aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients[J]. Haematologica,2017,102(3):433-444.
基本信息:
DOI：10.16389/j.cnki.cn42-1737/n.2025.01.004
中图分类号:R519
引用信息:
[1]余京,朱虹,胡红玲.侵袭性肺曲霉病1例并文献复习[J].江汉大学学报(自然科学版),2025,53(01):35-43.DOI:10.16389/j.cnki.cn42-1737/n.2025.01.004.
2025-02-25
2025-02-25